about
Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery?Is thoracoscopic patent ductus arteriosus closure superior to conventional surgery?Preoperative Aspirin Therapy Reduces Early Mortality in Patients Undergoing Cardiac Surgery.What is the impact of preoperative aspirin administration on patients undergoing coronary artery bypass grafting?Minimally invasive thoracoscopic closure versus thoracotomy in children with patent ductus arteriosus.Thromboembolic complications after an ankle joint open fracture in a patient with a history of deep vein thrombosis in the lower limbs.Combined mitral valve replacement associated with the Bentall procedure, diaphragmatic hernia repair and reconstruction of the pectus excavatum in a 26-year-old patient with Marfan syndrome.Electroporation-induced changes in normal immature rat myoblasts (H9C2).[Lack of left main and the operation of aortic valve replacement].Surgical closure of patent ductus arteriosus in extremely low birth weight infants less than 750 grams.The use of preoperative aspirin in cardiac surgery: A systematic review and meta-analysis.Does patient-prosthesis mismatch have a negative impact on outcomes following mitral valve replacement?In situ revascularisation with silver-coated polyester prostheses and arterial homografts in patients with aortic graft infection--a prospective, comparative, single-centre studyIs administration of dual-antiplatelet therapy beneficial for patients following off-pump coronary artery bypass grafting?Timing Strategy of Preoperative Aspirin and Its Impact on Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting: A Propensity Score Matching AnalysisConversion to thoracotomy of video-assisted thoracoscopic closure of patent ductus arteriosus
P50
Q27008480-26A86F40-1DC1-4900-87DE-57863D4E0CFCQ38544742-314FA706-C689-45CE-9FA7-731876A6C1B6Q38562827-32338484-896A-4BF1-9CDA-CC29FDA8F96CQ38972226-4F61A8CC-37C4-4192-ACCB-5B727EF662F6Q40417824-88630CB2-C162-4E29-BB6B-D7AAD9D3244FQ41993986-3F619A5D-41DE-4FF2-90E4-98759F30C8B5Q42384591-F1A9E869-0223-4987-8AC9-404A50ADCA09Q44124636-639DEA6D-54DF-4941-85EC-6CB5C9A17AA3Q45975659-E93A5172-7D4F-4BF1-937D-A99573D4A031Q47172082-B7FDC888-675D-4020-A27F-0D71998B4FA1Q48179830-300CFD47-F390-42B7-ACAD-F67EC5BB1E53Q49691953-65DA34AB-32BD-4F4E-843F-112495B7788FQ82542020-9BDF6B2C-A383-4E7B-B218-AFDD261D5140Q88371250-C285E39D-5341-4B18-8551-5BEE1846559CQ90696411-B535A6BD-733A-4EA6-B854-88B14E16B674Q90700526-A96E1749-4066-4969-BD04-79BF5FACDC73
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jakub Marczak
@ast
Jakub Marczak
@en
Jakub Marczak
@es
Jakub Marczak
@nl
type
label
Jakub Marczak
@ast
Jakub Marczak
@en
Jakub Marczak
@es
Jakub Marczak
@nl
prefLabel
Jakub Marczak
@ast
Jakub Marczak
@en
Jakub Marczak
@es
Jakub Marczak
@nl
P106
P21
P214
52152682584723312339
P31
P496
0000-0002-5364-3582
P735
P7859
viaf-52152682584723312339